[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] # $incys Incyte's KRAS G12D inhibitor is generating buzz at ESMO25 with positive responses reported in PDAC and other cancers. This development is driving significant social media engagement, indicating strong interest from the oncology community. ### About $incys Incyte Corporation (INCY) is a biopharmaceutical company focused on discovering, developing, and commercializing therapeutics. ### Engagements: X (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$incys/time-series/interactions.tsv) Current Value: X Daily Average: XXX X Week: XX -XX% X Month: XXX -XX% X Months: XXXXX -XX% X Year: XXXXXX +67% 1-Year High: XXXXX on 2025-03-17 1-Year Low: X on 2025-02-05 Engagements by network (24h): X: X ### Mentions: X (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$incys/time-series/posts_active.tsv) Current Value: X Daily Average: X X Week: X -XX% X Month: X no change X Months: XX -XX% X Year: XX +100% 1-Year High: X on 2024-12-12 1-Year Low: X on 2024-12-19 Mentions by network (24h): X: X ### Creators: X (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$incys/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $incys in the last XX hours which is no change from in the previous XX hours Daily Average: X X Week: X -XX% X Month: X -XX% X Months: X -XX% X Year: XX +27% 1-Year High: X on 2024-12-12 1-Year Low: X on 2024-12-08 ### Top $incys Social Posts Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "@RaajitRampal @clinadvances @doctorpemm @TaniaJain11 @Medscape @MKremyanskaya @doclucchesi @harrisoncn1 @VasNarasimhan @antengene @EricTokat @IcahnMountSinai @HealthTree @traviscooper93 @mpnadvocacy @GabyHobbs @Stemline @Blood_Cancers @SocietyofHemOnc @mpdrc @mlieducation @MDmasarova @JamesPharma @Genmab @mroliverbarnes @JFK_America @doctorpemm confirms $NVS will have to run a new trial for pelabresib assuming @VasNarasimhan still wants to advance the asset which seem unlikely at this point. h/t @CRTFund /297" [X Link](https://x.com/kinatsofrim/status/1990848863574405193) [@kinatsofrim](/creator/x/kinatsofrim) 2025-11-18T18:25Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Incyte's KRAS G12D inhibitor is generating buzz at ESMO25 with positive responses reported in PDAC and other cancers. This development is driving significant social media engagement, indicating strong interest from the oncology community.
Incyte Corporation (INCY) is a biopharmaceutical company focused on discovering, developing, and commercializing therapeutics.
Engagements 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XXX
X Week: XX -XX%
X Month: XXX -XX%
X Months: XXXXX -XX%
X Year: XXXXXX +67%
1-Year High: XXXXX on 2025-03-17
1-Year Low: X on 2025-02-05
Engagements by network (24h): X: X
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
X Week: X -XX%
X Month: X no change
X Months: XX -XX%
X Year: XX +100%
1-Year High: X on 2024-12-12
1-Year Low: X on 2024-12-19
Mentions by network (24h): X: X
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $incys in the last XX hours which is no change from in the previous XX hours
Daily Average: X
X Week: X -XX%
X Month: X -XX%
X Months: X -XX%
X Year: XX +27%
1-Year High: X on 2024-12-12
1-Year Low: X on 2024-12-08
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@RaajitRampal @clinadvances @doctorpemm @TaniaJain11 @Medscape @MKremyanskaya @doclucchesi @harrisoncn1 @VasNarasimhan @antengene @EricTokat @IcahnMountSinai @HealthTree @traviscooper93 @mpnadvocacy @GabyHobbs @Stemline @Blood_Cancers @SocietyofHemOnc @mpdrc @mlieducation @MDmasarova @JamesPharma @Genmab @mroliverbarnes @JFK_America @doctorpemm confirms $NVS will have to run a new trial for pelabresib assuming @VasNarasimhan still wants to advance the asset which seem unlikely at this point. h/t @CRTFund /297"
X Link @kinatsofrim 2025-11-18T18:25Z XXX followers, XXX engagements
/topic/$incys